https://www.pharmabcine.com/ForMedia/?q=YToyOntzOjEyOiJrZXl3b3JkX3R5cGUiO3M6MzoiYWxsIjtzOjQ6InBhZ2UiO2k6OTt9&bmode=view&idx=6377568&t=board
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC :...
Apr 20, 2021 - TitlePharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBCCategoryPress ReleasePharmAbcine announces Clinical Trial...
https://pharmabcine.com/ForMedia/?idx=169091527&bmode=view
PharmAbcine Successfully Completes Phase 1 Clinical Trial of TIE2-Targeting Antibody PMC-403 :...
Dec 18, 2025 - TitlePharmAbcine Successfully Completes Phase 1 Clinical Trial of TIE2-Targeting Antibody PMC-403CategoryPharmAbcine Successfully Completes Phase 1 Clinical...
https://pharmabcine.com/ForMedia/?q=YToyOntzOjEyOiJrZXl3b3JkX3R5cGUiO3M6MzoiYWxsIjtzOjQ6InBhZ2UiO2k6MTt9&page=3&category=263AL9Q85F
PharmAbcine
pharmabcine
https://www.pharmabcine.com/ForMedia/?q=YToxOntzOjEyOiJrZXl3b3JkX3R5cGUiO3M6MzoiYWxsIjt9&bmode=view&idx=13207012&t=board&category=17A4k565HI
AusBiotech 2022 : PharmAbcine
Oct 18, 2022 - TitleAusBiotech 2022CategoryCEO StoryPharmAbcine will be participating in upcoming AusBiotech 2022, taking place in Perth, Australia between October 26th and...
ausbiotechpharmabcine